Skip to content
Jiakan Yu

Research

Research

I study how emerging technologies reshape firms, industries and business models — and what keeps the ecosystems around them healthy.

01

Research themes

  1. 01

    Artificial intelligence

    How generative AI and agentic systems change organizational structure and value creation — and what stays defensible when AI is available to everyone.

  2. 02

    Digital innovation

    How firms orchestrate technological, organizational and ecosystem change, and turn technical possibility into operating reality.

  3. 03

    Business models

    How firms combine data, domain knowledge and customer relationships into advantage that lasts.

  4. 04

    Digital health

    How software-based medical innovation evolves across regulatory and market systems.

Current research

Survival and growth of generative-AI complementors

Building a product on top of a foundation model has never been easier, yet only some of these companies create value that lasts. I’m looking at which combinations of business-model choices help them grow, instead of remaining easy-to-replace “LLM wrappers.”

Future direction

Innovation governance in generative-AI ecosystems

Generative AI is becoming shared infrastructure. Around a handful of foundation-model providers, a whole ecosystem has grown up: the companies building on their APIs, the organizations adopting these tools, the people using them, and the regulators watching over it all.

That openness has sparked a wave of new products, but it also brings heavy dependence and uneven power. Next, I want to understand how the firms in the middle can manage that dependence and keep creating value — and what kind of governance keeps the ecosystem diverse, fair and safe.

02

Selected publications

  1. [3]

    Jiakan Yu, Jiajie Zhang, Shuto Miyashita, Shintaro Sengoku (2026). Innovation trajectory of Software as a Medical Device: Evidence from the US FDA-approved products. DIGITAL HEALTH, 12, 20552076261464265.

    Peer-reviewedDOI: 10.1177/20552076261464265

    › Abstract

    Background. Digital health innovation is reshaping healthcare, with Software as a Medical Device (SaMD) as a critical frontier. However, little is known about how enterprises evolve portfolios within this regulated market.

    Objectives. This study uses enterprise-level SaMD product portfolio data to characterize innovation trajectories in SaMD development and assess heterogeneity in these trajectories across enterprise characteristics.

    Methods. We identify 578 FDA-approved products from 289 enterprises (2012–2022) using the OpenFDA database. A multi-state model tracked innovation dynamics across 4 states: (1) one initial approval, (2) multiple approvals in identical area, (3) expansion into 2 areas, and (4) diversification into 3 or more areas. We apply Kaplan–Meier survival analysis with log-rank tests, competing-risk cumulative incidence analysis, and Cox proportional hazards regression to examine how enterprise size and industry classification influenced portfolio expansion, with right-censoring at the observation end date.

    Results. The analysis reveals stagnating innovation trajectories. 67% (n=193) of enterprises made only a single FDA submission. Kaplan–Meier estimation yielded a median time to first portfolio expansion of 8.41 years over a 10-year observation window, with large enterprises transitioning significantly faster than micro enterprises (p<0.001). Neither industry nor entry timing showed significant differences. Cumulative incidence functions show that the five-year cumulative incidence of focused expansion (33.6%) was five times that of diversification (6.4%). Cox proportional hazards regression confirms enterprise size as the dominant predictor (micro vs. large HR=0.19, p<0.005). Software enterprises show a significantly higher expansion hazard (HR=2.15, p=0.04), while other industry types showed no significant effect.

    Conclusions. Innovation of SaMD follows structurally constrained trajectories. We propose that this is caused by resource barrier that hinders smaller enterprises. Overcoming this barrier requires innovation systems that facilitate integration of complementary assets. Sustainable innovation depends on shifting from isolated product development to coordinated, multi-domain ecosystems.

  2. [2]

    Jiakan Yu, Jiajie Zhang, Shintaro Sengoku (2023). Innovation Process and Industrial System of US Food and Drug Administration–Approved Software as a Medical Device: Review and Content Analysis. Journal of Medical Internet Research, 25, e47505.

    Peer-reviewedDOI: 10.2196/47505

    › Abstract

    Background. There has been a surge in academic and business interest in software as a medical device (SaMD). SaMD enables medical professionals to streamline existing medical practices and make innovative medical processes such as digital therapeutics a reality. Furthermore, SaMD is a billion-dollar market. However, SaMD is not clearly understood as a technological change and emerging industry.

    Objective. This study aims to review the landscape of SaMD in response to increasing interest in SaMD within health systems and regulation. The objectives of the study are to (1) clarify the innovation process of SaMD, (2) identify the prevailing typology of such innovation, and (3) elucidate the underlying mechanisms driving the SaMD innovation process.

    Methods. We collected product information on 581 US Food and Drug Administration–approved SaMDs from the OpenFDA website and 268 company profiles of the corresponding manufacturers from Crunchbase, Bloomberg, PichBook.com, and other company websites. In addition to assessing the metadata of SaMD, we used correspondence and business process analysis to assess the distribution of intended use and how SaMDs interact with other devices in the medical process.

    Results. The current SaMD industry is highly concentrated in medical image processing and radiological analysis. Incumbents in the medical device industry currently lead the market and focus on incremental innovation, whereas new entrants, particularly startups, produce more disruptive innovation. We found that hardware medical device functions as a complementary asset for SaMD, whereas how SaMD interacts with the complementary asset differs according to its intended use. Based on these findings, we propose a regime map that illustrates the SaMD innovation process.

    Conclusions. SaMD, as an industry, is nascent and dominated by incremental innovation. The innovation process of the present SaMD industry is shaped by data accessibility, which is key to building disruptive innovation.

  3. [1]

    Itsuki Kageyama, Nobuki Hashiguchi, Jianfei Cao, Makoto Niwa, Yeongjoo Lim, Masanori Tsutsumi, Jiakan Yu, Shintaro Sengoku, Soichiro Okamoto, Seiji Hashimoto, Kota Kodama (2022). Determination of Waste Management Workers’ Physical and Psychological Load: A Cross-Sectional Study Using Biometric Data. International Journal of Environmental Research and Public Health, 19(23), 15964.

    Peer-reviewedDOI: 10.3390/ijerph192315964

    › Abstract

    Waste management workers experience high stress and physical strain in their work environment, but very little empirical evidence supports effective health management practices for waste management workers. Hence, this study investigated the effects of worker characteristics and biometric indices on workers’ physical and psychological loads during waste-handling operations. A biometric measurement system was installed in an industrial waste management facility in Japan to understand the actual working conditions of 29 workers in the facility. It comprised sensing wear for data collection and biometric sensors to measure heart rate (HR) and physical activity (PA) based on electrocardiogram signals. Multiple regression analysis was performed to evaluate significant relationships between the parameters. Although stress level is indicated by the ratio of low frequency (LF) to high frequency (HF) or high LF power in HR, the results showed that compared with workers who did not handle waste, those who did had lower PA and body surface temperature, higher stress, and lower HR variability parameters associated with higher psychological load. There were no significant differences in HR, heart rate interval (RRI), and workload. The psychological load of workers dealing directly with waste was high, regardless of their PA, whereas others had a low psychological load even with high PA. These findings suggest the need to promote sustainable work relationships and a quantitative understanding of harsh working conditions to improve work quality and reduce health hazards.

03

Conference presentations

  • 2026
    Open Innovation Configurations for Software as a Medical Device Implementation: A Qualitative Systematic Review of Multi-Stakeholder Perspectives. InnoTech 2026 (Poster)
  • 2025
    Innovation Trajectory of Software as a Medical Device Development: Evidence in the US FDA-Approved Products. ISPIM Osaka 2025 (Oral)
  • Mar 2023
    Industrial System and Innovation Process of Software as Medical Device (SaMD). Jiakan Yu. Japan MOT Society, 14th Annual Research Presentation Meeting (2022), Online
  • Oct 2022
    Innovation Process and Industrial Structure of Software as Medical Device (SaMD). Jiakan Yu. Japan Society for Research Policy and Innovation Management, 37th Annual Research Presentation Meeting (2022), Online
  • —
    Why the Declining Birthrate Has Accelerated Due to the Corona Crisis: An Analysis Based on SNS. Jiajie Zhang, Jiakan Yu. Society for Computational Social Science of Japan

04

Awards & invited lectures

  • Nov 2024
    Invited lecture: 10th DIA Medical Device Development Symposium. Hosted by DIA Japan
  • Mar 2023
    Award: Student Award. Japan Society for Research Policy and Innovation Management, 37th Annual Research Presentation Meeting (2022)

05

Research methods

Panel-data analysis · Survival analysis · Latent class analysis · Qualitative comparative analysis · Network analysis · Text mining & bibliometrics · Systematic review · Semi-structured interviews